A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

March 1, 2004

Primary Completion Date

February 1, 2005

Study Completion Date

February 1, 2005

Conditions

Osteoarthritis

Interventions

DRUG

MK0663, etoricoxib

DRUG

Comparator: celecoxib

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092781 - A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED) | Biotech Hunter | Biotech Hunter